Tottenham Acquisition I Ltd. (TOTA) to Combine with Clene Nanomedicine Inc.

Clene-nanomedicine-logo

Tottenham Acquisition I Ltd. (TOTA) to Combine with Clene Nanomedicine Inc.

Tottenham Acquisition I Limited (NASDAQ:TOTA) announced this morning that it had entered into a definite merger agreement with Clene Nanomedicine in a deal that would value the combined company at $542.5 million. Salt Lake City, Utah-based Clene is a clinical stage biopharmaceutical company focused on developing candidate treatments for neurodegenerative diseases. It has developed a
Read More
To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.

Leave a Reply